Shop By
Catalog No.
Product Name
Application
Product Information
Citations
-
folate metabolism inhibitor
Ethopabate is a folate metabolism inhibitor used in the prophylaxis and treatment of coccidiosis in chickens. -
Tyrosinase inhibitor
Kojic Acid is a tyrosinase inhibitor. It is a chelation agent produced by several species of fungi, especially Aspergillus oryzae, which has the Japanese common name koji. -
arachidonic acid metabolism inhibitor
Diethylcarbamazine citrate is an inhibitor of arachidonic acid metabolism in filarial microfilaria; is highly specific for several parasites and does not contain any toxic metallic elements. -
protein kinase A inhibitor
Warangalone is a prenylated isoflavone from the insecticidal plant Derris scandens that acts as a powerful inhibitor of protein kinase A. -
CRK12 inhibitor
GSK3186899 (DDD-853651) is an inhibitor of cdc-2-related kinase 12 (CRK12), with an EC50 of 1.4 μM for L. donovani in an intra-macrophage assay. -
virion mRNA(guanine-7-)-methyltransferase inhibitor
Sinefungin is a potent inhibitor of virion mRNA(guanine-7-)-methyltransferase, mRNA(nucleoside-2'-)-methyltransferase, and viral multiplication. -
asparaginyl endopeptidases inhibitors
RR-11a analog is a potent and selective inhibitors of asparaginyl endopeptidases (AE) (Legumain), with IC50 values of 4.5 nM, 4.5 nM and 31 nM for AE1 in Trichomonas Vaginalis, AE in Ixodes ricinus and AE in Schistosoma mansoni, respectively. -
Protein synthesis inhibitor
Blasticidin S is a nucleoside antibiotic isolated from Streptomyces griseochromogenes. Blasticidin S is a potent inhibitor of protein synthesis in both prokaryotic and eukaryotic cells. -
Cruzain inhibitor
Cruzain-IN-1 is a covalent and reversible Cruzain inhibitor, with an IC50 of 10 nM. -
Parasite Inhibitor
Gallinamide A TFA is a potent inhibitor of cathepsin L (CatL), with an IC50 of 17.6 pM. This peptide demonstrates significant antiviral activity by inhibiting SARS-CoV-2 infection, with an EC50 of 28 nM. Additionally, Gallinamide A TFA effectively inhibits Plasmodium falciparum, exhibiting an IC50 of 50 nM, making it a valuable reagent for research into parasitic infections and viral therapies. -
Parasite Inhibitor
CpCDPK1/TgCDPK1-IN-1 is a potent dual inhibitor of CpCDPK1 and TgCDPK1, demonstrating IC50 values of 10 nM and 5.0 nM, respectively. In addition, it shows inhibitory activity against Abl and Src kinases with IC50 values of 75 nM and 65 nM. This compound is suitable for research applications related to toxoplasmosis, providing valuable insights into the therapeutic targeting of these pathways. -
Parasite Inhibitor
Quinacrine acetate is a potent modulator of the cGAS-STING-TBK1 signaling pathway, exhibiting notable immune stimulatory activity. This compound has been investigated for its therapeutic potential in enhancing anti-tumor immunity and improving the efficacy of cancer immunotherapies by addressing the immunogenicity challenges faced by various tumors. Quinacrine acetate also represents a promising approach to mitigate the limitations associated with immune checkpoint inhibitors in cancer treatment. -
cell permeable TgPrxII inhibitor
Conoidin A is a cell permeable inhibitor of T. gondii enzyme peroxiredoxin II (TgPrxII). -
Parasite Inhibitor
Isopimpinellin acts as a potent inhibitor of parasitic activity. Isolated from Glomerella cingulata, this orally active compound prevents DNA adduct formation and inhibits skin tumor initiation induced by 7,12-dimethylbenz[a]anthracene. Additionally, Isopimpinellin demonstrates significant anti-leishmania activity, making it a valuable reagent for studies in parasitology and cancer research. -
Parasite Inhibitor
5,7,3',4'-Tetramethoxyflavone is a polymethoxyflavone that acts as a potent inhibitor of parasitic activity. Isolated from M. exotica, this compound demonstrates a range of bioactivities, including antifungal, antimalarial, antimycobacterial, and anti-inflammatory effects. Additionally, 5,7,3',4'-Tetramethoxyflavone exerts chondroprotective effects through modulation of β-catenin signaling, making it a valuable tool for research in both parasitology and inflammatory conditions. -
Parasite Inhibitor
Dihydroartemisinic acid, a biosynthetic precursor to the antimalarial compound Artemisinin, functions primarily as a parasite inhibitor. This compound demonstrates potent activity against malaria-causing Plasmodium species, making it valuable for research in malaria treatment and drug development. Its role in synthesizing Artemisinin positions it as an important reagent for studies focusing on antimalarial therapies. -
Parasite Inhibitor
Pervicoside B is a glycoside C derived from the sea cucumber Neothyone gibbosa, exhibiting potent antiparasitic activity as it effectively inhibits Leishmania mexicana promastigotes at concentrations of 5-10 μg/mL. Additionally, Pervicoside B displays significant antifungal properties against Aspergillus niger, with minimum inhibitory concentration (MIC) values ranging from 4.65 to 16.7 μg/mL. This compound holds promise for research applications focused on addressing parasitic infections and fungal diseases. -
Parasite Inhibitor
Hexyl gallate is an alkyl ester derivative of gallic acid that acts as a potent inhibitor of Plasmodium falciparum, exhibiting significant antimalarial activity with an IC50 of 0.11 mM. Additionally, it demonstrates antibacterial properties by inhibiting the production of virulence factors such as rhamnolipid and pyocyanin through the inhibition of the RhlR regulatory protein. This compound is valuable for research in parasitic infections and the development of new therapeutic agents. -
Parasite Inhibitor
Hydroxymetronidazole, a metabolite of Metronidazole, functions primarily as an inhibitor of parasitic infections. This nitroimidazole derivative exhibits significant antibacterial and antiprotozoal activities, making it valuable in research applications related to bacterial and protozoal diseases. It is particularly useful for studying conditions such as swine dysentery, as well as genital trichomoniasis in cattle, contributing to a better understanding of these veterinary health issues. -
Parasite Inhibitor
Asimilobine is an aporphine isoquinoline alkaloid derived from Magnolia obovata. This compound acts as a dopamine biosynthesis inhibitor and a serotonergic receptor antagonist, making it a valuable reagent for studying neurotransmitter pathways. Asimilobine exhibits significant antimalarial and anti-cancer activities, highlighting its potential applications in parasitology and oncology research. -
Parasite Inhibitor
Clindamycin B is a derivative of Clindamycin, primarily targeting parasitic infections. It exhibits potent inhibitory activity against various protozoa, making it useful in research related to parasitic diseases. Clindamycin B is valuable for studying mechanisms of action in parasite biology and evaluating therapeutic strategies for parasitic infections. -
Parasite Inhibitor
Milbemycin oxime is an orally active macrolide that serves as a potent inhibitor of parasite activity. This compound, a mixture of oxime derivatives related to milbemycin A4 and A3, selectively binds to glutamate-gated chloride channels, leading to paralysis and death of various intestinal nematodes and lung/heart worms. It is widely utilized in research focused on antiparasitic drug development and mechanisms of parasitic resistance. -
Parasite Inhibitor
Betulonic acid, a naturally occurring triterpene, primarily targets parasite inhibition. It demonstrates significant antiparasitic activity along with anti-tumor and anti-inflammatory properties. Research applications include studies on its efficacy against various parasites, as well as exploration in cancer and inflammatory disease models. -
Parasite Inhibitor
Methylene blue trihydrate is an inhibitor of guanylyl cyclase (sGC), monoamine oxidase A (MAO-A), and nitric oxide synthase (NOS). This compound exhibits a range of biological activities including antinociceptive, antimalarial, antidepressant, and anxiolytic effects. Methylene blue trihydrate is utilized in research applications related to methemoglobinemias, neurodegenerative disorders, and treatment of ifosfamide-induced encephalopathy. Additionally, it serves as a dye in various medical procedures, highlighting its versatility in scientific investigations. -
Parasites Inhibitor
Dehydroemetine is an orally active antiparasitic agent that targets and inhibits parasites, particularly Entamoeba histolytica. It exhibits key biological activity in combating parasitic infections and is used in research applications related to various parasitic diseases, including visceral leishmaniasis. -
Parasite Inhibitor
Trans-4-Methylcyclohexanamine is a key intermediate utilized in the development of inhibitors targeting Trypanosoma cruzi enzymes. This compound demonstrates significant biological activity against the parasite, making it a valuable tool for research in parasitology and drug discovery. Its applications extend to the exploration of therapeutic options for parasitic infections, particularly Chagas disease. -
Parasite Inhibitor
Diazinon is an irreversible acetylcholinesterase (AChE) inhibitor with primary applications in pest control as an insecticide. By inhibiting AChE, Diazinon leads to the accumulation of acetylcholine, resulting in overstimulation of acetylcholine receptors and disruption of nervous system function. Additionally, Diazinon generates reactive oxygen species (ROS), contributing to oxidative stress across various biological tissues. This compound is predominantly utilized in agricultural settings but may also hold implications for human and animal health research. -
Parasite Inhibitor
Licoflavone B is a flavonoid derived from Glycyrrhiza inflata, acting as a specific inhibitor of Schistosoma mansoni ATPase and ADPase, with IC50 values of 23.78 µM and 31.50 µM, respectively. This compound demonstrates significant anti-schistosomiasis activity, making it a valuable tool for researchers investigating therapeutic strategies against schistosomiasis. Its mechanism of action and inhibition of key enzymatic pathways underline its potential in parasitic disease research. -
Parasite Inhibitor
Aklomide (2-Chloro-4-nitrobenzamide) is a potent coccidiostat that targets protozoan parasites. Its primary biological activity involves inhibiting the growth and reproduction of coccidia, making it effective in preventing and controlling coccidiosis in poultry, particularly in chickens. Aklomide is valuable for researchers investigating parasite biology and developing strategies for managing coccidial infections. -
Parasite Inhibitor
8-Deoxygartanin, a prenylated xanthone derived from Garcinia mangostana, serves as a selective inhibitor of butyrylcholinesterase (BChE). This compound demonstrates significant antiplasmodial activity, with an IC50 value of 11.8 μM against the W2 strain of Plasmodium falciparum. Additionally, 8-Deoxygartanin inhibits NF-κB (p65) activation, displaying an IC50 of 11.3 μM, making it a valuable reagent for research in parasitic infections and inflammation pathways. -
Parasite Inhibitor
Dibenzosuberol is an effective inhibitor of Trypanosoma thiol reductase (TryR), showing significant biological activity against the parasite T. brucei with an EC50 value of 51.3 μM. This compound serves as a crucial intermediate in the synthesis of various compounds aimed at treating parasitic infections. Its properties make it valuable for research applications targeting trypanosomiasis and related diseases. -
Parasite Inhibitor
ACT-451840 is a potent oral inhibitor specifically targeting Plasmodium falciparum, including both sensitive and resistant strains. This compound demonstrates significant activity against all asexual blood stages of the parasite, characterized by a rapid onset of action. ACT-451840 exhibits a mechanism of action akin to that of artemisinin derivatives, effectively facilitating the elimination of the malaria pathogen. It serves as a valuable research tool for studies related to malaria treatment and resistance. -
Parasite Inhibitor
2',4'-Dihydroxy-6'-Methoxyacetophenone is a phenolic acetophenone that acts as a parasite inhibitor, derived from Artemisia annua. This compound serves as an effective analog of Artemisinin, making it valuable in malaria research. Its properties contribute to the understanding of parasite biology and the development of potential therapeutic strategies against malaria. -
Parasite Inhibitor
Nepodin is a quinone oxidoreductase (PfNDH2) inhibitor derived from Rumex crispus. It exhibits significant antidiabetic and antimalarial activities by stimulating the translocation of GLUT4 to the plasma membrane via AMPK activation. This compound serves as a valuable tool for research into metabolic disorders and parasitic infections, facilitating studies on glucose metabolism and potential therapeutic interventions. -
Parasite Inhibitor
Guanfu base H (Atisinium chloride) is a diterpenoid alkaloid derived from Aconitum coreanum, functioning primarily as a parasite inhibitor. It exhibits significant antiplasmodial activity against the malarial Plasmodium falciparum strains TM4/8.2 (wild type) and K1CB1, exhibiting IC50 values of 4 µM and 3.6 µM, respectively. This compound is a valuable tool for research in malaria treatment and drug development. -
Parasite Inhibitor
1R-cis-Permethrin is a potent insecticide with neurotoxic properties that primarily targets sodium channels in neuronal membranes. By prolonging the activation state of these channels, it disrupts normal neuronal function, resulting in paralysis and death of target pests. This compound is utilized extensively in research for studying the mechanisms of insect neurotoxicity and developing pest control strategies. -
Parasite Inhibitor
Albendazole sulfone is a metabolism-derived compound of Albendazole, primarily targeting parasitic infections. It demonstrates significant anti-parasitic activity against Echinococcus multilocularis metacestodes, making it a valuable reagent for research focused on parasitic diseases and treatment efficacy. Its application extends to studies concerning drug resistance and therapeutic approaches in veterinary and human medicine. -
Parasite Inhibitor
Clofentezine is a potent growth inhibitor with primary activity against acarine pests, specifically targeting mites. This compound effectively disrupts the developmental stages of parasites, making it valuable for research applications in pest control and agricultural science. Its mechanism of action makes clofentezine an important reagent for studying mite population dynamics and developing strategies for management in agricultural settings. -
Parasite Inhibitor
Laetanine is a noraporphine alkaloid derived from Litsea laeta, known for its potent antiplasmodial activity. This compound is also present in the leaf extracts of Phoebe tavoyana (Meissn) Hook. Laetanine is primarily utilized in research applications targeting parasite inhibition, offering potential insights into therapeutic strategies against malaria and related diseases. -
Parasite Inhibitor
Cratoxylone is a potent antiplasmodial agent isolated from the bark of Cratoxylum cochinchinense. It exhibits activity against malaria-causing parasites, making it a valuable tool in the study of parasitic infections. Its biological properties may facilitate research into novel treatments for malaria and enhance understanding of parasite biology. -
Parasite Inhibitor
2-Benzoxazolinone is an anti-leishmanial compound that exhibits an LC50 of 40 μg/mL against Leishmania donovani. This small molecule serves as a versatile building block in chemical synthesis. Additionally, 1,3-Benzoxazol-2(3H)-one derivatives demonstrate significant antimicrobial activity against various Gram-positive and Gram-negative bacteria, as well as yeasts. Certain derivatives have also been identified as effective anti-quorum sensing agents, making them valuable for research applications in microbiology and infectious disease studies. -
Parasite Inhibitor
4′-Hydroxy-2′-methylacetophenone acts as a parasite inhibitor, demonstrating significant ciliate toxicity. This compound effectively inhibits the growth of Tetrahymena pyriformis, with an IC50 value of 0.65 mM. It is a valuable reagent for studies focused on parasitic biology and potential therapeutic applications targeting ciliate organisms.
